RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
Services and Capabilities

In Vitro Pharmacology, Bioassay Development, and High-Throughput Screening (HTS)

Identifying and developing high-throughput screening assays to validate novel drug targets

Our pharmacologists are skilled at elucidating mechanism of action and adapting R&D assays for use with automated liquid handling and incorporation into HTS assays. We have the molecular, biological, and pharmacological expertise to develop and optimize bioassays for HTS campaigns.

We support these campaigns with our proprietary chemical libraries for GPCRs, ion channels, and protein-protein interactions. We also support secondary screens to assess ligand bias and receptor selectivity, as well as hit-to-lead optimization.

Collaborate with Us

Learn more about how our molecular biology and in vitro pharmacology services can support your drug discovery and development projects.

Start a Conversation